Dr. Nir Barzilai is the director of the Institute for Aging Studies at the Albert Einstein College of Medicine (New York). As well as a professor in the field of medicine, genetics, and endocrinologist. That is, on the one hand, he deeply understands the device of our body, understands all the subtleties of the action of drugs. On the other hand, Professor Barzilai is a scientist, researcher, one of the world classics of life extension studies. We first met him at an international conference on the genetics of aging and longevity in Sochi in 2014. And now, when exactly five years have passed, I met again at the largest conference “Undoing Aging” (to cancel aging, in English) in Berlin. This Congress, where more than 500 participants from all over the world came, organized international research support funds to combat aging SENS Research Foundation and Forever Healthy Foundation. Visit thetribuneworld.com for more in this matter.
Five years for science is probably a short time, but still: what has changed in the field of life extension over the years?
There are changes, and even what. Previously, I had only hope that serious research on aging would appear and someday practical attempts would begin. And now we are talking about the embodiment of scientific discoveries in life. We are preparing full clinical trials. Still, aging itself has never been recognized as a target for prevention at the state level.
And you want to prove that aging can actually be slowed down, be engaged